GB Sciences, Inc. (GBLX)

GB Sciences Income Statement

Financials in millions USD. Fiscal year is April - March.

Year	2022	2021	2020	2019	2018
Revenue	0	0	0	3.12	3.45
Revenue Growth (YoY)	-	-	-	-9.67%	37.61%
Cost of Revenue	0.06	0.07	0.05	4	3.25
Gross Profit	-0.06	-0.07	-0.05	-0.88	0.21
Selling, General & Admin	1.67	1.87	2	6.48	15.8
Research & Development	0	0	0	0	0
Other Operating Expenses	0.1	0.01	-0.23	-2.09	-3.37
Operating Expenses	1.67	1.87	2	6.48	15.8
Operating Income	-1.67	-1.87	-2	-12.01	-15.59
Interest Income	0	0	0	0	0
Interest Expense	0.18	0.47	1.29	1.63	5.19
Other Expense / Income	2.27	-2.2	0.05	-2.09	2.35
Pretax Income	-4.13	-0.15	-3.33	-11.55	-24.15
Income Tax	2,631,565	-1.8	1.45	0.09	0.53
Net Income	-2,631,569.13	1.66	-4.78	-11.64	-23.65
Shares Outstanding (Basic)	358	318	285	258	210
Shares Outstanding (Diluted)	358	318	285	258	210
Shares Change	12.62%	11.37%	10.35%	23.34%	57.63%
EPS (Basic)	-7356.48	0.01	-0.02	-0.04	-0.11
EPS (Diluted)	-7356.48	0.01	-0.02	-0.04	-0.11
Free Cash Flow	-1.56	-2.07	-2.48	-4.77	-19.82
Free Cash Flow Per Share	-0.00	-0.01	-0.01	-0.02	-0.09
Gross Margin	-	-	-	-28.25%	6.03%
Operating Margin	-	-	-	-384.86%	-451.41%
Profit Margin	-	-	-	-372.86%	-684.70%
Free Cash Flow Margin	-	-	-	-152.98%	-573.83%
EBITDA	-1.51	-1.79	-2.18	-9.2	-18.34
EBITDA Margin	-	-	-	-294.68%	-530.89%
Depreciation & Amortization	0.06	0.07	0.05	0.26	0.62
EBIT	-1.57	-1.86	-2.23	-9.45	-18.96
EBIT Margin	-	-	-	-302.97%	-548.92%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.